How oncology is adapting to the rise of artificial intelligence
Panel at MedCity CONVERGE discussed the practical applications of AI in the treatment of cancers.
The Benihana of cancer vaccines: How are medical oncologists advancing immunotherapy?
At the MedCity CONVERGE conference, medical oncologist Dr. Joshua Brody, the director of the lymphoma immunotherapy program at Mount Sinai Hospital, talked about some of the hype and hope of CAR-T and checkpoint blockade immunotherapy treatments.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
How value-based care and oncology come together in the healthcare ecosystem
At the MedCity CONVERGE conference in Philadelphia on July 11, experts from Harvard Business School, payer Highmark and tech company Integra Connect explored how their organizations are approaching the intersection of cancer and value-based care.
What sparks the investment passions of David Shaywitz of Takeda Ventures? (Q&A)
The Takeda Ventures Senior Partner will take part in the panel discussion Trends in Oncology Investing at the MedCity CONVERGE Conference July 11-12 in Philadelphia.
Where do AI and oncology converge?
The MedCity CONVERGE conference in Philadelphia on July 11-12 will take a closer look at how companies like Deep 6 AI are making their mark at the intersection of artificial intelligence and cancer care.
What cancer patients want and need on their care journey
At the MedCity CONVERGE conference in Philadelphia on July 11-12, a panel of experts will discuss how to make the care journey a bit more bearable for those living with cancer.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Which startups will be showing what they’re doing for cancer care, precision medicine at CONVERGE?
As the MedCity CONVERGE conference in Philadelphia July 11-12 approaches, here's a look at the innovation that's taking root in the cancer care and precision medicine sectors presented by health IT and life science entrepreneurs.
Precision medicine: Where we are and where we’re going
A panel at MedCity CONVERGE in July will discuss the challenges preventing precision medicine from reaching its full potential and how we can overcome them.
VICE documentary shows new frontier in drug pricing debate: DIY drugs
Experts discuss the multitude of factors feeding high drug prices and some of the solutions that policymakers have proposed.
A Q&A with Foundation Medicine’s chairman-turned VC
Michael Pellini, the featured speaker at MedCity's CONVERGE conference next month, holds forth on his new VC gig at Bill Maris-founded Section 32, the practice of oncology, and how healthcare must get more tightly integrated with tech.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
MedCity CONVERGE: An oncology innovation conference where health IT and biotech intersect
The Philadelphia event from July 11-12 highlights the most compelling topics in healthcare from breaking down the data silos in cancer research, how to scale precision medicine, the reimbursement hurdles for genetic testing, AI applications and investment trends in oncology and precision medicine.
Cell-therapy startup raises $33.5M from Canaan, Bill Maris’s Section 32 and others
The San Francisco startup has a cloud-based platform to prevent supply chain mistakes in personalized cell and gene therapy where patients' re-engineered cells need to be delivered back to the correct individual.
Senate OKs Right to Try legislation as part of FDA User Fee Reauthorization bill
The Senate approved the feel good legislation which was hotly debated at the MedCity CONVERGE conference this week.
Virtual reality has a role to play in cancer treatment and prevention
In cancer care, virtual reality could be enlisted to improve patient therapy and physician education with minimal cost to hospital systems.
We need a futures market for healthcare and 3 more takeaways from Biden Cancer Initiative president
Greg Simon, Biden Cancer Initiative President touched on several topics from changing the culture of science, to highlighting some of the collaborations that emerged from the Cancer Moonshot in a fireside chat at MedCity's CONVERGE conference.